Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 3 | 502 | 35 | 0.4728 | 0.5724 | 0.0697 | 0.0768 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 1 | 642 | 104 | 0.5447 | 0.4489 | 0.1620 | 0.1849 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 2 | 572 | 111 | 0.4668 | 0.4489 | 0.1941 | 0.1849 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 3.160 | uM | 72 | hr | 3 | 413 | 82 | 0.3351 | 0.4489 | 0.1985 | 0.1849 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 1 | 642 | 98 | 0.5508 | 0.6679 | 0.1526 | 0.1517 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 832 | 118 | 0.7229 | 0.6679 | 0.1418 | 0.1517 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 3 | 859 | 138 | 0.7300 | 0.6679 | 0.1607 | 0.1517 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 1 | 609 | 115 | 0.5002 | 0.5785 | 0.1888 | 0.1867 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 2 | 652 | 130 | 0.5285 | 0.5785 | 0.1994 | 0.1867 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.316 | uM | 72 | hr | 3 | 843 | 145 | 0.7067 | 0.5785 | 0.1720 | 0.1867 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 655 | 120 | 0.5417 | 0.4404 | 0.1832 | 0.1902 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 591 | 123 | 0.4738 | 0.4404 | 0.2081 | 0.1902 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 3 | 368 | 66 | 0.3058 | 0.4404 | 0.1793 | 0.1902 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 1 | 413 | 133 | 0.2835 | 0.2531 | 0.3220 | 0.3208 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 2 | 367 | 115 | 0.2551 | 0.2531 | 0.3134 | 0.3208 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 3.160 | uM | 72 | hr | 3 | 324 | 106 | 0.2207 | 0.2531 | 0.3272 | 0.3208 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 593 | 164 | 0.4344 | 0.5184 | 0.2766 | 0.2893 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 2 | 711 | 196 | 0.5214 | 0.5184 | 0.2757 | 0.2893 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 865 | 273 | 0.5994 | 0.5184 | 0.3156 | 0.2893 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 493 | 140 | 0.3574 | 0.3881 | 0.2840 | 0.2937 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 2 | 557 | 171 | 0.3908 | 0.3881 | 0.3070 | 0.2937 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 3 | 579 | 168 | 0.4161 | 0.3881 | 0.2902 | 0.2937 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 1 | 590 | 212 | 0.3827 | 0.3044 | 0.3593 | 0.3533 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 472 | 162 | 0.3139 | 0.3044 | 0.3432 | 0.3533 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 3 | 333 | 119 | 0.2167 | 0.3044 | 0.3574 | 0.3533 |